FSCN1 can also serve as a diagnostic marker for distinguishing triple-negative subtypes from other breast cancer types,71,203,209 thyroid carcinoma from benign lesions,267 and uterine leiomyosarcoma from leiomyoma variants.270. Here, FSCN1 is linked to breast carcinoma.